CTS21166
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTS21166, covering 2008-07-09 to 2008-07-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of CTS21166 to Treat Alzheimer Disease [Phase 1]